What's breaking now, across thousands of outlets.
The oral drug remibrutinib cut relapse rates in patients with relapsing multiple sclerosis, beating a rival treatment in both studies
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
Naglaa Shoukry and Petronela Ancuta, researchers in the Immunopathology Research Theme at the Centre de recherche du CHUM (CRCHUM), are shedding new light on one of the greatest challenges in HIV…
South Africa recorded 15 human rabies deaths by 26 August 2026, including confirmed and probable cases. Health officials urged anyone bitten, scratched or exposed to an animal’s saliva to wash the…
More than two dozen of Aesto's clients affected by the December 2025 cyberincident.
Bladder cancer is the 10th most common cancer. Delve into the most promising strides in bladder cancer treatment. The post Bladder cancer treatment: where are we standing in 2026?
More than 3,000 people have died from the ongoing Ebola outbreak in the Democratic Republic of Congo, DRC, health authorities confirmed on Wednesday.
About 25% of heart attacks are silent, especially among older adults and diabetics, according to cardiology professor Dr. Khaled Al-Nemer.
